SCOPUS 정보 검색 플랫폼

Volumn 183, Issue 6, 2001, Pages 844-849

Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment

(4) Bernstein, David I a Harrison, Christopher J b,d Tomai, Mark A c Miller, Richard L c

a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER (United States)

b CREIGHTON UNIVERSITY (United States)

c 33M Corporation (United States)

d University of Louisville School of Medicine (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT; INTERLEUKIN 2; RESIQUIMOD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL RESPONSE MODIFIERS; CELLS, CULTURED; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMIDAZOLES; INTERFERONS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; RANDOM ALLOCATION; RECURRENCE; TIME FACTORS;

EID: 0035869132 PISSN: 00221899 EISSN: None Source Type: Journal
DOI: 10.1086/319262 Document Type: Article

Times cited : (71)

References (28)

1
- 0030744945
- Herpes simplex virus type 2 in the United States, 1976 to 1994
- (1997) N Engl J Med , vol.337 , pp. 1105-1111
- Fleming, D.T.¹ McQuillan, G.M.² Johnson, R.E.³

2
- 0032903874
- New developments in the epidemiology, natural history and management of genital herpes
- (1999) Antiviral Res , vol.42 , pp. 1-14
- Stanberry, L.¹ Cunningham, A.² Mertz, G.³

3
- 0024357248
- Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection
- (1989) Ann Intern Med , vol.110 , pp. 882-887
- Langenberg, A.¹ Benedetti, J.² Jenkins, J.³ Ashley, R.⁴ Winter, C.⁵ Corey, L.⁶

4
- 0034704798
- Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
- (2000) N Engl J Med , vol.342 , pp. 844-850
- Wald, A.¹ Zeh, J.² Selke, S.³

5
- 0023718970
- Acyclovir suppression of frequently recurring genital herpes: Efficacy and diminishing need during successive years of treatment
- (1988) JAMA , vol.260 , pp. 2227-2230
- Straus, S.E.¹ Croen, D.K.² Sawyer, M.H.³

6
- 0031030411
- Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: A multicenter, double-blind, placebo-controlled trial
- Collaborative Famciclovir Genital Herpes Research Group
- (1997) Arch Intern Med , vol.10 , pp. 343-349
- Mertz, G.J.¹ Loveless, M.O.² Levin, M.J.³

7
- 0031688110
- Valciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study
- International Valaciclovir HSV Study Group
- (1998) J Infect Dis , vol.178 , pp. 603-610
- Reitano, M.¹ Tyring, S.² Lang, W.³

8
- 0028875151
- Immunomodulation and antiviral activities of the imidazoquinoline S-28463
- (1995) Antiviral Res , vol.28 , pp. 253-264
- Tomai, M.A.¹ Gibson, S.J.² Imbertson, L.M.³

9
- 0031976655
- Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
- (1998) Antimicrob Agents Chemother , vol.42 , pp. 789-794
- Beutner, K.R.¹ Tyring, S.K.² Trofatter, K.F.³

10
- 0031853904
- A randomized controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
- (1998) J Infect Dis , vol.178 , pp. 551-555
- Tyring, S.K.¹ Arany, I.² Stanley, M.A.³

11
- 0032619393
- Imiquimod applied topically: A novel immune response modifier and new class of drug
- (1999) Int J Immunopharmacol , vol.21 , pp. 1-14
- Miller, R.L.¹ Gerster, J.F.² Owens, M.L.³ Slade, H.B.⁴ Tomai, M.A.⁵

12
- 0031282514
- Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463
- (1997) Cytokine , vol.9 , pp. 837-845
- Wagner, T.L.¹ Horton, V.L.² Carlson, G.L.³

13
- 0031900829
- Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463
- (1998) J Invest Dermatol , vol.110 , pp. 734-739
- Imbertson, L.M.¹ Beaurline, J.M.² Couture, A.M.³

14
- 0028071434
- Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs
- (1994) Antimicrob Agents Chemother , vol.38 , pp. 2059-2064
- Harrison, C.J.¹ Miller, R.L.² Bernstein, D.I.³

15
- 0027958391
- Cytokine induction in mice by the immunomodulator imiquimod
- (1994) J Leukoc Biol , vol.55 , pp. 234-240
- Reiter, M.J.¹ Testerman, T.L.² Miller, R.L.³ Weeks, C.E.⁴ Tomai, M.A.⁵

16
- 0029032284
- Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609
- (1995) J Interferon Cytokine Res , vol.15 , pp. 537-545
- Gibson, S.J.¹ Imbertson, L.M.² Wagner, T.L.³

17
- 0033543947
- Dendritic cell maturation and subsequent enhanced T-cell simulation induced with novel synthetic immune response modifier R-848
- (1999) Cell Immunol , vol.197 , pp. 62-72
- Ahonen, C.L.¹ Gibson, S.J.² Smith, R.M.³

18
- 0022518085
- Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: Effects of acyclovir
- (1986) J Gen Virol , vol.67 , pp. 1601-1612
- Bernstein, D.I.¹ Stanberry, L.R.² Harrison, C.J.³ Kappes, J.C.⁴ Myers, M.G.⁵

19
- 0024231126
- Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
- (1988) Antiviral Res , vol.10 , pp. 209-223
- Harrison, C.J.¹ Jenski, L.² Voychehovski, T.³ Bernstein, D.I.⁴

20
- 0025897420
- Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy
- (1991) J Immunol , vol.146 , pp. 3571-3577
- Bernstein, D.I.¹ Harrison, C.J.² Jenski, L.J.³ Myers, M.G.⁴ Stanberry, L.R.⁵

21
- 0029931269
- DNA immunization against experimental genital herpes simplex virus infection
- (1996) J Infect Dis , vol.173 , pp. 800-807
- Bourne, N.¹ Stanberry, L.R.² Bernstein, D.I.³ Lew, D.⁴

22
- 0033540341
- Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod
- (1999) Cell Immunol , vol.10 , pp. 10-19
- Wagner, T.L.¹ Ahonen, C.L.² Couture, A.M.³

23
- 0033775777
- Adjuvant activities of the immune response modifier, R-848. Comparison with CpG ODN
- (2000) Cell Immunol , vol.204 , pp. 64-74
- Vasilakos, J.P.¹ Smith, R.M.² Gibson, S.J.³

24
- 0030961152
- + cytotoxic T lymphocyte responses
- (1997) Proc Natl Acad Sci USA , vol.94 , pp. 10289-10294
- Posavad, C.M.¹ Koelle, D.M.² Shaughnessy, M.F.³ Corey, L.⁴

25
- 0001585502
- Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes
- (1998) J Clin Invest , vol.101 , pp. 1500-1508
- Koelle, D.M.¹ Posavad, C.M.² Barnum, G.R.³ Johnson, M.L.⁴ Frank, J.M.⁵ Corey, L.⁶

26
- 0028835820
- Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea pigs
- (1995) Vaccine , vol.13 , pp. 72-76
- Bernstein, D.I.¹ Harrison, C.J.² Tepe, E.R.³ Shahwan, A.⁴ Miller, R.L.⁵

27
- 0027389176
- Adjuvant effects of imiquimod on a herpes simplex type 2 glycoprotein vaccine in guinea pigs
- (1993) J Infect Dis , vol.167 , pp. 731-735
- Bernstein, D.I.¹ Miller, R.L.² Harrison, C.J.³

28
- 4244156949
- Immuno-modulation to decrease recurrences of herpes genitalis: A double-blind, dose ranging study of topical R-848
- (Toronto). Washington, DC: American Society for Microbiology
- (2000) 40th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 263
- Spruance, S.L.¹ Tyring, S.² Bleazard, C.³ Vanderstraten, M.⁴ Smith, M.⁵ Meng, T.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.